vitrolife-group-logo

From Pronuclear Assessment to Ploidy: Time-Lapse, 2.1PNs and the Clinical Importance of Embryo Classification

Join leading experts in embryology, genetics, and clinical practice as they explore emerging evidence around PN designation, the role of time-lapse technology in improving pronuclear identification, and how ploidy assessment may help inform classification and improve outcomes.

October 8th, 2026
10:00 AM (ET)
4:00 PM (CET)

Quality all the way

Through the latest research, consensus guidance, and real-world clinical experience, this webinar will examine how a more precise approach to classification may help clinics reconsider embryos that may have otherwise been deprioritized.

Moderator
David O'Rourke, Clinical Support Manager, Vitrolife Group



Please fill out the form to register for the webinar.




All content © Vitrolife 2026. Products shown on this website might not be available on all markets.

Privacy policy | Legal notice | Cookie policy